Current situation of sedative-hypnotic drugs in the treatment of patients with comorbided depression and insomnia
10.13699/j.cnki.1001-6821.2018.01.021
- VernacularTitle:镇静催眠药物治疗抑郁症共病失眠的研究现状
- Author:
Zhan-Zhang WANG
1
;
De-Wei SHANG
;
Xiao-Jia NI
;
Hao-Yang LU
;
Ming ZHANG
;
Yu-Guan WEN
Author Information
1. 广州医科大学附属脑科医院、广州市惠爱医院药学部
- Keywords:
depression;
insomnia;
sedative-hypnotic drugs
- From:
The Chinese Journal of Clinical Pharmacology
2018;34(1):77-80,84
- CountryChina
- Language:Chinese
-
Abstract:
Insomnia and depression are common mental disorders and there exists bidirectionality between sleep symptoms and depressive symptoms.Cognitive behavioral therapy for insomnia (CBT-I) is recommanded first in patients with accute or chronic insomnia.Phannacotherapy treatment is recommended when CBT-I is insufficient or patients are comorbided with depression or other mental diseases.Pharmacotherapy treatment options include antidepressants,benzodiazepines,non-benzodiazepines,atypical antipsychotics as monotherapy or cotherapy.The aim of the present review was to discuss the selection and clinical application of sedative-hypnotic drugs in patients with comorbid depression and insomnia.
